Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription


4 Am J Hematol
1 Ann Hematol
1 Biochem Pharmacol
5 Blood
4 BMC Cancer
1 Br J Haematol
3 Cancer
1 Clin Infect Dis
2 Eur J Haematol
1 Int J Hematol
1 J Clin Oncol
2 Leuk Lymphoma
1 Leuk Res
2 Leukemia
3 N Engl J Med
2 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. ZHU HH, Yang MC, Wang F, Lou YJ, et al
    Identification of a novel NUP98-RARA fusion transcript as the 14(th) variant of acute promyelocytic leukemia.
    Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25807.

  2. JABBOUR E, Kantarjian H
    Chronic Myeloid Leukemia: 2020 Update on Diagnosis, Therapy and Monitoring.
    Am J Hematol. 2020 Apr 2. doi: 10.1002/ajh.25792.
    PubMed         Abstract available

  3. LOSCOCCO GG, Mannelli F, Mannelli L, Vergoni F, et al
    A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: morphological and molecular characteristics of a highly aggressive disease.
    Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25806.

  4. MORSIA E, Reichard K, Pardanani A, Tefferi A, et al
    WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic.
    Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25811.

    Ann Hematol

  5. OZBAGCIVAN O, Akarsu S, Nazli EC, Lebe B, et al
    Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia.
    Ann Hematol. 2020 Mar 27. pii: 10.1007/s00277-020-04009.

    Biochem Pharmacol

  6. FARAONI I, Giansanti M, Voso MT, Lo-Coco F, et al
    Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.
    Biochem Pharmacol. 2019;167:133-148.
    PubMed         Abstract available


  7. GANG EJ, Kim HN, Hsieh YT, Ruan Y, et al
    Integrin alpha6 mediates drug resistance of acute lymphoblastic B-cell leukemia.
    Blood. 2020 Mar 27. pii: 454180. doi: 10.1182/blood.2019001417.
    PubMed         Abstract available

  8. KLEIN E, Bidet A
    MYC and KMT2A multiple extra copies in acute myeloid leukemia.
    Blood. 2020;135:1070.

  9. GARDNER RA, Ceppi F, Rivers J, Annesley C, et al
    Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy.
    Blood. 2019;134:2149-2158.
    PubMed         Abstract available

  10. OTTEMA S, Mulet-Lazaro R, Beverloo HB, Erpelinck CAJ, et al
    Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Blood. 2020 Mar 27. pii: 454178. doi: 10.1182/blood.2019003701.
    PubMed         Abstract available

  11. HASSERJIAN RP, Steensma DP, Graubert TA, Ebert BL, et al
    Clonal Hematopoiesis and Measurable Residual Disease Assessment in Acute Myeloid Leukemia.
    Blood. 2020 Mar 13. pii: 452698. doi: 10.1182/blood.2019004770.
    PubMed         Abstract available

    BMC Cancer

  12. MEYER HJ, Ponisch W, Schmidt SA, Wienbeck S, et al
    Clinical and imaging features of myeloid sarcoma: a German multicenter study.
    BMC Cancer. 2019;19:1150.
    PubMed         Abstract available

  13. YAN A, Erdman L, Sung L, Bernstein S, et al
    Teetering on a liver's edge: a case report highlighting clinical decision-making in thrombocytopenia.
    BMC Cancer. 2019;19:1058.
    PubMed         Abstract available

  14. ACIK DY, Bankir M, Baylan FA, Aygun B, et al
    Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
    BMC Cancer. 2019;19:1086.
    PubMed         Abstract available

  15. CHOI HG, Zehnder JL, Lee YK, Lim H, et al
    Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort.
    BMC Cancer. 2019;19:1148.
    PubMed         Abstract available

    Br J Haematol

  16. COGLE CR, Collins B, Turner D, Pettiford LC, et al
    Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
    Br J Haematol. 2020 Apr 1. doi: 10.1111/bjh.16629.


  17. PRINTZ C
    States that expanded medicaid coverage note increased patient use of hormonal therapies.
    Cancer. 2019;125:1767.

  18. PRINTZ C
    Chemotherapy can induce relapse in some patients with leukemia.
    Cancer. 2020;126:1601.

  19. PRINTZ C
    Radiation from computed tomography scans is associated with increased risk for thyroid cancer and leukemia.
    Cancer. 2020;126:1601.

    Clin Infect Dis

  20. BOSE P, McCue D, Wurster S, Wiederhold NP, et al
    Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study.
    Clin Infect Dis. 2020 Apr 1. pii: 5814277. doi: 10.1093.
    PubMed         Abstract available

    Eur J Haematol

  21. SITGES M, Boluda B, Garrido A, Morgades M, et al
    Scute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). study of 61 patients treated with intensive protocols.
    Eur J Haematol. 2020 Apr 3. doi: 10.1111/ejh.13417.
    PubMed         Abstract available

  22. ZAJAC-SPYCHALA O, Irga-Jaworska N, Drozynska E, Muszynska-Roslan K, et al
    Mixed phenotype acute leukemia (MPAL): biological profile, clinical characteristic and treatment outcomes: report of the population-based study.
    Eur J Haematol. 2020 Mar 28. doi: 10.1111/ejh.13413.
    PubMed         Abstract available

    Int J Hematol

  23. YAMAGUCHI H, Inokuchi K
    No sex-related difference in achievement of treatment-free remission following treatment with tyrosine kinase inhibitors in chronic myeloid leukemia.
    Int J Hematol. 2020 Mar 31. pii: 10.1007/s12185-020-02865.

    J Clin Oncol

  24. GRAFF SL
    The Cattle Don't Care.
    J Clin Oncol. 2019;37:1136-1138.

    Leuk Lymphoma

  25. CAI P, Wu Q, Wang Y, Yang X, et al
    An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia.
    Leuk Lymphoma. 2020 Mar 31:1-7. doi: 10.1080/10428194.2020.1742910.
    PubMed         Abstract available

  26. DUCOURNEAU B, Fenwarth L, Duployez N, Lambert J, et al
    Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype.
    Leuk Lymphoma. 2020 Mar 29:1-3. doi: 10.1080/10428194.2020.1742905.

    Leuk Res

  27. YANG W, Xie J, Hou R, Chen X, et al
    Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression.
    Leuk Res. 2020;92:106351.
    PubMed         Abstract available


  28. HEROLD T, Rothenberg-Thurley M, Grunwald VV, Janke H, et al
    Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
    Leukemia. 2020 Mar 30. pii: 10.1038/s41375-020-0806.
    PubMed         Abstract available

  29. GODFREY L, Crump NT, O'Byrne S, Lau IJ, et al
    H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
    Leukemia. 2020 Apr 2. pii: 10.1038/s41375-020-0808.
    PubMed         Abstract available

    N Engl J Med

  30. MAURO MJ, Hughes TP
    Asciminib in Relapsed Chronic Myeloid Leukemia. Reply.
    N Engl J Med. 2020;382:1379.

  31. SAHIN I, Reagan JL
    Asciminib in Relapsed Chronic Myeloid Leukemia.
    N Engl J Med. 2020;382:1378-1379.

  32. SYKES DB, Zhang EW, Karp Leaf RS, Nardi V, et al
    Case 10-2020: An 83-Year-Old Man with Pancytopenia and Acute Renal Failure.
    N Engl J Med. 2020;382:1258-1266.

    PLoS One

  33. NAGEL S, Scherr M, MacLeod RAF, Pommerenke C, et al
    NKL homeobox gene activities in normal and malignant myeloid cells.
    PLoS One. 2019;14:e0226212.
    PubMed         Abstract available

  34. ALI EA, Kalli M, Wan D, Nakamura R, et al
    Characterization of human FcepsilonRIalpha chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines.
    PLoS One. 2019;14:e0221034.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  35. KIM JH, Penson AV, Taylor BS, Petrini JHJ, et al
    Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.
    Proc Natl Acad Sci U S A. 2019;116:15178-15183.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.